BPC
BIO icon

Banque Pictet & Cie’s Bio-Rad Laboratories Class A BIO Stock Holding History

Banque Pictet & Cie’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,440
Closed -$2.13M – 501
2023
Q1 		$2.13M Buy
4,440
+2,002
+82% +$937K 0.02% 264
2022
Q4 		$1.03M Buy
2,438
+1,055
+76% +$426K 0.01% 401
2022
Q3 		$577K Sell
1,383
-1,885
-58% -$940K 0.01% 478
2022
Q2 		$1.62M Sell
3,268
-781
-19% -$407K 0.02% 343
2022
Q1 		$2.28M Buy
4,049
+299
+8% +$180K 0.02% 308
2021
Q4 		$2.83M Buy
+3,750
New +$2.81M 0.02% 279

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Banque Pictet & Cie's BIO Position: Q2 2023 in Review

Banque Pictet & Cie sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 4,440 shares — an estimated $2.13M sold.

Banque Pictet & Cie first reported a position in BIO in Q4 2021 and held it in 6 quarters. The position peaked at $2.83M in Q4 2021. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Banque Pictet & Cie reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 4,440 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $2.13M.
  • Banque Pictet & Cie first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 6 quarters.
  • Banque Pictet & Cie's Bio-Rad Laboratories Class A position peaked at $2.83M in Q4 2021.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.